Live birth rate and neonatal outcomes following interventional embolization of hydrosalpinx
Authors:
Open Access
- 1 December 2022
- journal article
- research article
- Published by Springer Nature in Reproductive Health
- Vol. 19 (1) , 1-10
Abstract
Background: Hydrosalpinx has a negative effect on the pregnancy outcomes of in vitro fertilization and embryo transfer (IVF-ET), and the pretreatment for hydrosalpinx play an important role in improving the outcomes of IVF-ET. This study aimed to investigate the impacts of interventional embolization of hydrosalpinx on the live birth rate and neonatal outcome after in-vitro fertilization. Method: In the present retrospective study, 3351 women receiving the first frozen embryo transfer (FET) after freeze-all policy were reviewed. Patients who received interventional embolization of hydrosalpinx (n = 1268) were included in the study group and those with hydrosalpinx-free bilateral fallopian tube obstruction (n = 2083) in the control group. The primary outcome was live birth (LB) rate; the secondary endpoints included rates of implantation, clinical pregnancy (CP), multiple pregnancy, and pregnancy loss. Results: The LB rate was similar between embolization group (39.91%) and control group (43.21%) (P > 0.05). The rate of implantation (35.81% vs. 32.24%), CP (50.84% vs. 47%) and multiple pregnancy rate (28.71% vs. 24.16%) in the control group were significantly higher than in the embolization group (P < 0.05). The miscarriage rate (39.91%, vs 43.21%, P > 0.05), ectopic gestation rate (2.35% vs 2.83%, P > 0.05), and ongoing pregnancy rate (41.56% vs 44.89%, P > 0.05) were comparable between two groups. After adjustment for confounding factors, interventional embolization of hydrosalpinx was found to have no influence on the LB rate. The thicker endometrium, more embryos transferred, and transfer of blastocyst stage embryos significantly increased the LB rate and CP rate. Conclusion: The interventional embolization of hydrosalpinx can achieve the LB rate similar to that of hydrosalpinx-free obstruction patients with less risk, less pain and reduced medical cost. Thus, embolization of hydrosalpinx is one of the preferable clinical treatments for patients with hydrosalpinx.Keywords
This publication has 35 references indexed in Scilit:
- A retrospective analysis of the effect of salpingectomy on serum antiMüllerian hormone level and ovarian reserveAmerican Journal of Obstetrics and Gynecology, 2015
- Management of hydrosalpinx before IVF: A literature reviewJournal of Obstetrics and Gynaecology, 2014
- Essure® for management of hydrosalpinx prior to in vitro fertilisation—a systematic review and pooled analysisBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- Salpingectomy for hydrosalpinx prior to in vitro fertilizationFertility and Sterility, 2008
- Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trialHuman Reproduction, 2008
- Management of hydrosalpinx before or during in vitro fertilization–embryo transfer: a national postal survey in FranceFertility and Sterility, 2006
- Migrating Filshie clip: an unmentioned complication of female sterilisationBMJ Sexual & Reproductive Health, 2006
- Hydrosalpinx fluid induced embryotoxicity and lipid peroxidationReproductive Toxicology, 2004
- Characterization of epithelial cell culture from human hydrosalpinges and effects of its conditioned medium on embryo development and sperm motilityHuman Reproduction, 2003
- Secretion of Steroids, Growth Factors, and Cytokines by Immortalized Mouse Granulosa Cell Lines1Biology of Reproduction, 1994